Total Payments
$17,613
2024 Payments
$4,843
Companies
21
Transactions
119
Medicare Patients
3,574
Medicare Billing
$246,978
Payment Breakdown by Category
Other$10,450 (59.3%)
Food & Beverage$5,040 (28.6%)
Travel$1,373 (7.8%)
Education$750.00 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $6,250 | 5 | 35.5% |
| Food and Beverage | $5,040 | 106 | 28.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,450 | 2 | 19.6% |
| Travel and Lodging | $1,373 | 4 | 7.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $750.00 | 1 | 4.3% |
| Education | $750.00 | 1 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $3,724 | 7 | $0 (2022) |
| ABBVIE INC. | $3,530 | 4 | $0 (2024) |
| CooperVision Inc. | $3,432 | 30 | $0 (2023) |
| Glaukos Corporation | $2,038 | 3 | $0 (2023) |
| BIOTISSUE HOLDINGS INC. | $1,678 | 13 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $601.12 | 8 | $0 (2024) |
| Alcon Vision LLC | $512.10 | 11 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $333.55 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $299.13 | 6 | $0 (2022) |
| Oyster Point Pharma, Inc. | $267.12 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,843 | 26 | ABBVIE INC. ($2,530) |
| 2023 | $3,748 | 15 | Glaukos Corporation ($2,038) |
| 2022 | $3,392 | 22 | Allergan, Inc. ($2,250) |
| 2021 | $825.13 | 7 | Allergan, Inc. ($585.84) |
| 2020 | $3,203 | 7 | CooperVision Inc. ($2,328) |
| 2019 | $920.56 | 20 | CooperVision Inc. ($611.14) |
| 2018 | $499.23 | 14 | CooperVision Inc. ($335.09) |
| 2017 | $182.93 | 8 | Alcon Laboratories Inc ($161.70) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | LUMIGAN (Drug) | Grant | Cash or cash equivalent | $1,250.00 | General |
| Category: EYE CARE | ||||||
| 12/14/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | BIOTISSUE HOLDINGS INC. | — | Travel and Lodging | Cash or cash equivalent | $659.95 | General |
| 12/09/2024 | BIOTISSUE HOLDINGS INC. | — | Travel and Lodging | Cash or cash equivalent | $299.00 | General |
| 12/09/2024 | BIOTISSUE HOLDINGS INC. | — | Travel and Lodging | Cash or cash equivalent | $289.00 | General |
| 12/09/2024 | BIOTISSUE HOLDINGS INC. | — | Travel and Lodging | Cash or cash equivalent | $125.00 | General |
| 11/21/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 11/11/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $1.46 | General |
| 11/07/2024 | LKC Technologies, Inc. | — | Food and Beverage | In-kind items and services | $76.77 | General |
| 10/30/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Ophthalmology | ||||||
| 10/23/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Ophthalmology | ||||||
| 10/16/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: EYE CARE | ||||||
| 10/13/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $18.83 | General |
| 10/13/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $1.99 | General |
| 10/11/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $1.46 | General |
| 10/04/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 09/16/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $81.11 | General |
| 06/13/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $119.07 | General |
| Category: Dry eyes | ||||||
| 06/10/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $18.83 | General |
| 06/10/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $8.78 | General |
| 05/21/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device), BIOTRUE | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Ophthalmology | ||||||
| 05/15/2024 | BIOTISSUE HOLDINGS INC. | PROKERA (Device) | Food and Beverage | In-kind items and services | $149.70 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 04/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Dry eyes | ||||||
| 03/21/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $101.70 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 989 | 1,137 | $254,828 | $67,702 |
| 2022 | 10 | 911 | 1,056 | $207,118 | $59,488 |
| 2021 | 8 | 904 | 1,093 | $132,880 | $65,389 |
| 2020 | 8 | 770 | 927 | $109,840 | $54,400 |
Total Patients
3,574
Total Services
4,213
Medicare Billing
$246,978
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 293 | 297 | $89,100 | $24,475 | 27.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 199 | 240 | $51,360 | $13,562 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 136 | $40,936 | $10,435 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 129 | $27,477 | $7,109 | 25.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 34 | 34 | $12,070 | $3,678 | 30.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 62 | 82 | $12,546 | $2,771 | 22.1% |
| 92134 | Imaging of retina | Office | 2023 | 88 | 97 | $9,409 | $2,531 | 26.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 51 | 52 | $4,628 | $1,255 | 27.1% |
| 92250 | Photography of the retina | Office | 2023 | 50 | 51 | $4,794 | $1,246 | 26.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 19 | $2,508 | $638.56 | 25.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 349 | 362 | $95,960 | $28,651 | 29.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 220 | 312 | $53,996 | $16,400 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 39 | $8,194 | $2,512 | 30.7% |
| 92134 | Imaging of retina | Office | 2022 | 83 | 92 | $9,988 | $2,503 | 25.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 63 | 82 | $13,250 | $2,361 | 17.8% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 25 | 25 | $7,120 | $1,944 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 20 | $6,020 | $1,815 | 30.2% |
| 92133 | Imaging of optic nerve | Office | 2022 | 49 | 54 | $5,312 | $1,312 | 24.7% |
| 92250 | Photography of the retina | Office | 2022 | 42 | 45 | $3,978 | $1,056 | 26.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 24 | 25 | $3,300 | $932.32 | 28.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 340 | 351 | $49,140 | $28,286 | 57.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 281 | 426 | $38,340 | $24,895 | 64.9% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 43 | 43 | $6,880 | $3,920 | 57.0% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 66 | 85 | $15,725 | $3,572 | 22.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 67 | 75 | $10,125 | $1,697 | 16.8% |
About Dr. James Flickinger, OD
Dr. James Flickinger, OD is a Optometrist healthcare provider based in Scranton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184636284.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Flickinger, OD has received a total of $17,613 in payments from pharmaceutical and medical device companies, with $4,843 received in 2024. These payments were reported across 119 transactions from 21 companies. The most common payment nature is "Grant" ($6,250).
As a Medicare-enrolled provider, Flickinger has provided services to 3,574 Medicare beneficiaries, totaling 4,213 services with total Medicare billing of $246,978. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Scranton, PA
- Active Since 08/13/2006
- Last Updated 12/01/2022
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1184636284
Products in Payments
- LUMIGAN (Drug) $5,793
- MyDay Contact Lens (Device) $2,384
- KXL system (not refurbished) (Device) $2,038
- Clariti Contact Lens (Device) $1,033
- RESTASIS MULTIDOSE (Drug) $500.00
- MIEBO (Drug) $351.67
- Cequa (Drug) $333.55
- XIIDRA (Drug) $268.31
- TYRVAYA (Drug) $267.12
- DAILIES (Device) $216.30
- TOTAL30 (Device) $201.50
- DEXTENZA (Drug) $185.60
- INFUSE (Device) $181.43
- PROKERA (Device) $172.21
- Precision 1 (Device) $167.12
- INVELTYS (Drug) $154.16
- AIR OPTIX (Device) $133.31
- RESTASIS (Drug) $125.00
- ACTHAR (Biological) $121.97
- EYSUVIS (Drug) $101.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Scranton
Jennifer Randle, Od, OD
Optometrist — Payments: $18,426
Optometrist $18,426
Joseph Shovlin, Od, OD
Optometrist — Payments: $12,935
Optometrist $12,935
John Boyle, Od, OD
Optometrist — Payments: $5,624
Optometrist $5,624
Mary Jordan-Flickinger, Od, OD
Optometrist — Payments: $4,543
Optometrist $4,543
Natalie Boyce, Od, OD
Optometrist — Payments: $3,504
Optometrist $3,504
Dr. Emily Sparks, O.d, O.D
Optometrist — Payments: $2,801
Optometrist $2,801